News

May 4, 2017May 4, 2017

Cell Group Thought to Be Cause of Taxane Resistance in Triple Negative Breast Cancer Identified in Mice

News

A study in mice has shown that the mechanism behind taxane resistance in triple-negative breast cancer (TNBC) relies on the expansion of a specific cancer cell population, a CD49f+ population, with tumor-initiating properties. ... Read more

May 3, 2017

COMET Trial Now Recruiting to Study Active Surveillance in Low-risk DCIS

News

A new breast cancer clinical trial called COMET (NCT02926911) is now enrolling participants to evaluate the risks and benefits of a monitoring approach vs. a full-mode attack with surgery and ... Read more

May 2, 2017May 4, 2017

Australia’s Monash Cancer Centre is First to Treat Breast Cancer Patient with iCAD’s Xoft System

News

A woman with early-stage breast cancer became the first patient to receive a single, concentrated dose of intraoperative radiation therapy (IORT) following surgery using the Xoft system, in a clinical study taking place ... Read more

May 1, 2017

Tumor ‘Paint’ Aids Breast Cancer Surgeons and Well-Tolerated by Patients, Study Reports

News

BLZ-100 (tozuleristide) was found to be well-tolerated by patients and to make breast cancer tumors more easily seen during surgery in a Phase 1 clinical trial, Blaze Bioscience announced. BLZ-100 was ... Read more

April 28, 2017May 25, 2017

FDA Advisory Committee to Review Puma’s Request for Neratinib Approval

News

A U.S. Food and Drug Administration advisory committee will begin a review on May 24 of Puma Biotechnology‘s neratinib as a breast cancer treatment. If the independent Oncologic Drug Advisory Committee ... Read more

April 27, 2017

Breast Cancer and Fractures Study Prompts Revision in Bone-loss-prevention Guidelines

News

A study suggesting that breast cancer patients on aromatase-inhibitors (AIs) are at higher risk of fractures has prompted several international medical associations to revise guidelines aimed at preventing bone loss in these ... Read more

April 27, 2017April 28, 2017

ICAD Displaying its Radiation System for Residual Breast Cancer at Conference

News

ICAD is showcasing its Xoft radiation system for treating post-surgery residual breast cancer at the American Society of Breast Surgeons annual meeting in Las Vegas. Two leading breast-cancer surgeons agreed to be ... Read more

April 26, 2017April 26, 2017

Abemaciclib Combo Seen to Slow Progression in Phase 3 Advanced Breast Cancer Trial

News

An interim analysis from the Phase 3 trial known as MONARCH 3 showed that adding abemaciclib to an aromatase inhibitor — Femara (letrozole) or Arimidex (anastrozole) — helped to treat certain postmenopausal women ... Read more

April 25, 2017

AbbVie’s Veliparib and Chemotherapy Combo Trial Failed in Early Triple Negative Breast Cancer

News

AbbVie’s investigational oral PARP inhibitor veliparib was not effective against early-stage triple-negative breast cancer when given in combination with chemotherapy, the company recently announced. Despite the drawback, AbbVie researchers believe ... Read more

April 24, 2017April 24, 2017

Eating Strawberries May Prevent Breast Cancer, Mouse Study Suggests

News

Strawberry extract can inhibit the growth and spread of highly aggressive breast cancer, various European studies in mice and lab-grown cells have shown. While the findings suggest that strawberry consumption could prevent ... Read more